Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Staphylococcus aureus (methicillin-susceptible) |
>2 |
>8 |
0.25 - 64 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
948 |
Staphylococcus aureus (methicillin-susceptible) |
3 |
4 |
0.06 - 32 |
Gentamicin (Gentamycin, Garamycin) |
1056 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
0.12 - 32 |
Ceftriaxone (Rocephin) |
475 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
0.125 - 32 |
Ceftriaxone (Rocephin) |
113 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
0.5 - 8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
7 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
0.5 - >64 |
Ceftriaxone (Rocephin) |
55 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
4 |
2 - 8 |
Cefteram |
317 |
Staphylococcus aureus (methicillin-susceptible) |
≤4 |
≤4 |
≤4 - ? |
Mupirocin (Bactroban) |
604 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
8 |
0.5 - 16 |
Cefaclor (Ceclor, Ceclor CD) |
120 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
8 |
0.5 - 32 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
1464 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
8 |
2 - 16 |
Ceftriaxone (Rocephin) |
371 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
8 |
? - ? |
Moxalactam (Latamoxef) |
1389 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
16 |
≤0.125 - ? |
MSI-78 (Peptide) |
65 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
16 |
? - ? |
Ceftriaxone (Rocephin) |
36 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
32 |
≤0.015 - >32 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
371 |
Staphylococcus aureus (methicillin-susceptible) |
>=4 |
≥32 |
≤0.06 - >=32 |
Ampicillin (Omnipen) |
475 |
Staphylococcus aureus (methicillin-susceptible) |
4 |
64 |
0.125 - 64 |
Gentamicin (Gentamycin, Garamycin) |
1464 |
Staphylococcus aureus (methicillin-susceptible) |
8 |
8 |
2 - >64 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
55 |
Staphylococcus aureus (methicillin-susceptible) |
8 |
8 |
2 - >64 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
55 |
Staphylococcus aureus (methicillin-susceptible) |
8 |
8 |
4 - 8 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1491 |
Staphylococcus aureus (methicillin-susceptible) |
>=8 |
≥16 |
≤0.06 - >=16 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
475 |
Staphylococcus aureus (methicillin-susceptible) |
>8 |
>16 |
? - ? |
Ampicillin (Omnipen) |
36 |
Staphylococcus aureus (methicillin-susceptible) |
8 |
64 |
0.06 - 128 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
178 |
Staphylococcus aureus (methicillin-susceptible) |
16 |
16 |
2 - 32 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
113 |
Staphylococcus aureus (methicillin-susceptible) |
16 |
16 |
2 - 32 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
113 |
Staphylococcus aureus (methicillin-susceptible) |
>16 |
>16 |
4 - >16 |
Bacitracin (Baci-IM) |
120 |
Staphylococcus aureus (methicillin-susceptible) |
16 |
16 |
8 - 16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
952 |
Staphylococcus aureus (methicillin-susceptible) |
16 |
16 |
8 - 16 |
Mannopeptimycins (δ) |
89 |